glp 1 drugs in pill form Weight-Loss Study Compares Effectiveness to Injectables and stomach upset Everything You Need to Know

Pharma is pivoting toward preventive medicine as GLP-1 receptor agonists (drugs like Ozempic) show promise not just for obesity and diabetes but potentially for slowing aging itself

Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats

Participants taking tirzepatide lost an average of 15.3% of their body weight after a year, while those on semaglutide lost about 8.3%

These combined metabolic effects generate that familiar feeling of fullness after a meal

In contrast, those with preclinical obesity can be managed with health counseling and monitoring to mitigate progression

10.1016/j.ijpharm.2024.123991